when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Type 2 Diabetes · news · pharmadog

← back to Type 2 Diabetes

News mentioning Type 2 Diabetes

86 stories

18d'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrandfiercebiotech

23dMedicaid will let states use ‘tiers’ to determine medical frailtystat

25dKura spins diabetes work into a Lilly-backed biotech startupbiopharma dive

25dCaspian launches with $50M, Lilly support to advance disease-modifying diabetes betbiospace

25dKura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapyfiercebiotech

Sep 4, 26Menarini signs $771M deal to take Gan & Lee GLP-1 to European marketfiercebiotech

Sep 3, 26‘Tactical athletes’ get new guidance for cardiovascular fitnessstat

Sep 1, 26As MAHA champions nutrition, it’s ignoring the experts, dietitians saystat

Aug 31, 26The next frontier: Advancing foundation models with multimodal databiopharma dive

Aug 28, 26Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjarobiospace

Aug 27, 26Myriad catalysts on deck for obesity’s brightest stars as market continues to acceleratebiospace

Aug 26, 26FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosisfiercebiotech

Aug 25, 26Lilly takes oral obesity race abroad with UK launch of Foundayobiospace

Aug 24, 26Americans bought 12% less soda under new SNAP restrictions, study saysstat

Aug 24, 26Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismfiercebiotech

Aug 21, 26Novo Nordisk starts trialing lower maintenance doses of oral Wegovybiospace

Aug 19, 26Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?biospace

Aug 12, 26STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and morestat

Aug 11, 26Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsstat

Aug 11, 26Abbott teams with Google Health on AI-powered health insights appfiercebiotech

Aug 10, 26Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetesraps

Aug 5, 26Lilly climbs, Novo falls as obesity drug battle intensifiesbiopharma dive

Aug 5, 26Amgen’s MariTide stands alone after obesity cull while analysts seek more M&Abiospace

Aug 5, 26‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growthfiercebiotech

Aug 5, 26Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed datafiercebiotech

Aug 4, 26Amgen drops early-stage obesity drug, upping pressure on MariTidefiercebiotech

Jul 30, 26Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemptionstat

Jul 30, 26FDA updates product-specific guidelines for injectable peptidesraps

Jul 30, 26FDA unveils FY 2027 user fee ratesraps

Jul 28, 26After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenstat

← prevpage 2 of 3next →